Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-007403

General Counsel sold 1,302 shares at $0.67 ($873)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Edward General Counsel 2024-01-23 Sale −1,302 $0.67 $873 234,232 D: show line 1 in the form
Open-market sales · 1,302 sh · avg $0.67 · $873
Loading xslF345X05/ownership.xml…